Excessive pricing in the pharmaceutical sector

Concurrences Review, in association with Skadden, White & Case and Compass Lexecon, is please to invite you to a lunch discussion with leading pharmaceutical practitioners and regulators to hear unique perspectives and insights on excessive pricing in the industry.

EXCESSIVE PRICING IN THE PHARMACEUTICAL SECTOR

Brussels, Thursday 22 November 2018 - 12:00* - 14:30

with

Paul Csiszar
Director (E), DG COMP, Brussels

Robert O’Donoghue
Professor, Brussels School Competition
Barrister, Brick Court Chambers, London

John Davies
Senior Vice President, Compass Lexecon, London/Paris
Former Head of the Competition Division, OECD, Paris

James Killick
Partner, White & Case, Brussels

This panel will be chaired by

Frédéric Jenny
Chairman, OECD Competition Committee, Paris
Professor, Co-Director of the European Center for Law and Economics, ESSEC, Paris
President, Concurrences Review International Committee

This panel will be introduced by

Ingrid Vandenborre
Partner, Skadden, Brussels

*PLEASE NOTE THAT THIS LUNCHTALK WILL EXCEPTIONALLY START AT 12:00!

Radisson Blu, 47 rue du Fossé aux Loups, Brussels 1000, Belgium

Documentation

---

Assimakis Komninos, James Killick, The UK Competition Appeal Tribunal announces its provisional judgment in an appeal against the CMA’s infringement decision in an excessive price case (Pfizer / Flynn), 7 June 2018, e-Competitions Bulletin June 2018, Art. N° 87652 Raphaël De Coninck, Alessandra Tonazzi, Mélanie Thill-Tayara, Elina Koustoumpardi, Recent developments in pharma antitrust, September 2017, Concurrences Review N° 3-2017, Art. N° 84663, www.concurrences.com Raphaël De Coninck, Excessive Prices: An overview of EU and national case law, 21 June 2018, e-Competitions Bulletin Excessive prices, Art. N° 86604 OECD Competition Division, The OECD publishes the background material on excessive prices in pharmaceutical markets in preparation for the 2018 competition week, 3 October 2018, e-Competitions Bulletin November 2018, Art. N° 88369